series-b
Stage
2010
Founded
1
Investors
About
Digital Diagnostics develops FDA-cleared autonomous AI technology that diagnoses diabetic retinopathy at the point-of-care without physician input, aiming to improve clinical accuracy, patient outcomes, and health equity worldwide.
Explore Digital Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.